世界のリウマチ治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Rheumatology Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5049 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、リウマチ治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（関節リウマチ、変形性関節症、狼瘡、痛風、強直性脊椎炎、その他）、用途別市場規模（小売薬局、オンライン薬局、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・リウマチ治療の市場動向 ・企業の競争状況、市場シェア ・リウマチ治療の種類別市場規模（関節リウマチ、変形性関節症、狼瘡、痛風、強直性脊椎炎、その他） ・リウマチ治療の用途別市場規模（小売薬局、オンライン薬局、病院） ・リウマチ治療の北米市場規模2016-2027（アメリカ、カナダ） ・リウマチ治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・リウマチ治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・リウマチ治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・リウマチ治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Pfizer、Bristol-Myers Squibb Company、Merck、Amgen、Janssen Biotech、Novartis AG、Genentech、Takeda Pharmaceutical、Sanofi） ・結論

A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market.
The global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025.

Market Analysis and Insights: Global Rheumatology Therapeutics Market
The global Rheumatology Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rheumatology Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rheumatology Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rheumatology Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rheumatology Therapeutics market.

Global Rheumatology Therapeutics Scope and Market Size
Rheumatology Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatology Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Rheumatoid Arthritis
Osteoarthritis
Lupus
Gout
Ankylosing Spondylitis
Other

Segment by Application
Retail Pharmacy
Online Pharmacy
Hospitals

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck
Amgen
Janssen Biotech
Novartis AG
Genentech
Takeda Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatology Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Rheumatoid Arthritis
1.2.3 Osteoarthritis
1.2.4 Lupus
1.2.5 Gout
1.2.6 Ankylosing Spondylitis
1.2.7 Other
1.3 Market by Application
1.3.1 Global Rheumatology Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacy
1.3.3 Online Pharmacy
1.3.4 Hospitals
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rheumatology Therapeutics Market Perspective (2016-2027)
2.2 Rheumatology Therapeutics Growth Trends by Regions
2.2.1 Rheumatology Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rheumatology Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Rheumatology Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Rheumatology Therapeutics Industry Dynamic
2.3.1 Rheumatology Therapeutics Market Trends
2.3.2 Rheumatology Therapeutics Market Drivers
2.3.3 Rheumatology Therapeutics Market Challenges
2.3.4 Rheumatology Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rheumatology Therapeutics Players by Revenue
3.1.1 Global Top Rheumatology Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Rheumatology Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Rheumatology Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rheumatology Therapeutics Revenue
3.4 Global Rheumatology Therapeutics Market Concentration Ratio
3.4.1 Global Rheumatology Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Therapeutics Revenue in 2020
3.5 Rheumatology Therapeutics Key Players Head office and Area Served
3.6 Key Players Rheumatology Therapeutics Product Solution and Service
3.7 Date of Enter into Rheumatology Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rheumatology Therapeutics Breakdown Data by Type
4.1 Global Rheumatology Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Rheumatology Therapeutics Forecasted Market Size by Type (2022-2027)

5 Rheumatology Therapeutics Breakdown Data by Application
5.1 Global Rheumatology Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Rheumatology Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rheumatology Therapeutics Market Size (2016-2027)
6.2 North America Rheumatology Therapeutics Market Size by Type
6.2.1 North America Rheumatology Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Rheumatology Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Rheumatology Therapeutics Market Size by Type (2016-2027)
6.3 North America Rheumatology Therapeutics Market Size by Application
6.3.1 North America Rheumatology Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Rheumatology Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Rheumatology Therapeutics Market Size by Application (2016-2027)
6.4 North America Rheumatology Therapeutics Market Size by Country
6.4.1 North America Rheumatology Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Rheumatology Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Rheumatology Therapeutics Market Size (2016-2027)
7.2 Europe Rheumatology Therapeutics Market Size by Type
7.2.1 Europe Rheumatology Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Rheumatology Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Rheumatology Therapeutics Market Size by Type (2016-2027)
7.3 Europe Rheumatology Therapeutics Market Size by Application
7.3.1 Europe Rheumatology Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Rheumatology Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Rheumatology Therapeutics Market Size by Application (2016-2027)
7.4 Europe Rheumatology Therapeutics Market Size by Country
7.4.1 Europe Rheumatology Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Rheumatology Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rheumatology Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Rheumatology Therapeutics Market Size by Type
8.2.1 Asia-Pacific Rheumatology Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rheumatology Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rheumatology Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Rheumatology Therapeutics Market Size by Application
8.3.1 Asia-Pacific Rheumatology Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rheumatology Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rheumatology Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Rheumatology Therapeutics Market Size by Region
8.4.1 Asia-Pacific Rheumatology Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rheumatology Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rheumatology Therapeutics Market Size (2016-2027)
9.2 Latin America Rheumatology Therapeutics Market Size by Type
9.2.1 Latin America Rheumatology Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Rheumatology Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Rheumatology Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Rheumatology Therapeutics Market Size by Application
9.3.1 Latin America Rheumatology Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Rheumatology Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Rheumatology Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Rheumatology Therapeutics Market Size by Country
9.4.1 Latin America Rheumatology Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Rheumatology Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rheumatology Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Rheumatology Therapeutics Market Size by Type
10.2.1 Middle East & Africa Rheumatology Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rheumatology Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rheumatology Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Rheumatology Therapeutics Market Size by Application
10.3.1 Middle East & Africa Rheumatology Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rheumatology Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rheumatology Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Rheumatology Therapeutics Market Size by Country
10.4.1 Middle East & Africa Rheumatology Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rheumatology Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Rheumatology Therapeutics Introduction
11.1.4 AbbVie Revenue in Rheumatology Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Rheumatology Therapeutics Introduction
11.2.4 Pfizer Revenue in Rheumatology Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Rheumatology Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Rheumatology Therapeutics Business (2016-2021)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Rheumatology Therapeutics Introduction
11.4.4 Merck Revenue in Rheumatology Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Rheumatology Therapeutics Introduction
11.5.4 Amgen Revenue in Rheumatology Therapeutics Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Janssen Biotech
11.6.1 Janssen Biotech Company Details
11.6.2 Janssen Biotech Business Overview
11.6.3 Janssen Biotech Rheumatology Therapeutics Introduction
11.6.4 Janssen Biotech Revenue in Rheumatology Therapeutics Business (2016-2021)
11.6.5 Janssen Biotech Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Rheumatology Therapeutics Introduction
11.7.4 Novartis AG Revenue in Rheumatology Therapeutics Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Genentech
11.8.1 Genentech Company Details
11.8.2 Genentech Business Overview
11.8.3 Genentech Rheumatology Therapeutics Introduction
11.8.4 Genentech Revenue in Rheumatology Therapeutics Business (2016-2021)
11.8.5 Genentech Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Details
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Rheumatology Therapeutics Introduction
11.9.4 Takeda Pharmaceutical Revenue in Rheumatology Therapeutics Business (2016-2021)
11.9.5 Takeda Pharmaceutical Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Rheumatology Therapeutics Introduction
11.10.4 Sanofi Revenue in Rheumatology Therapeutics Business (2016-2021)
11.10.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rheumatology Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Rheumatoid Arthritis
Table 3. Key Players of Osteoarthritis
Table 4. Key Players of Lupus
Table 5. Key Players of Gout
Table 6. Key Players of Ankylosing Spondylitis
Table 7. Key Players of Other
Table 8. Global Rheumatology Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Rheumatology Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Rheumatology Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Rheumatology Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Rheumatology Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Rheumatology Therapeutics Market Share by Regions (2022-2027)
Table 14. Rheumatology Therapeutics Market Trends
Table 15. Rheumatology Therapeutics Market Drivers
Table 16. Rheumatology Therapeutics Market Challenges
Table 17. Rheumatology Therapeutics Market Restraints
Table 18. Global Rheumatology Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Rheumatology Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Rheumatology Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatology Therapeutics as of 2020)
Table 21. Ranking of Global Top Rheumatology Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Rheumatology Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Rheumatology Therapeutics Product Solution and Service
Table 25. Date of Enter into Rheumatology Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rheumatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Rheumatology Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Rheumatology Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Rheumatology Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Rheumatology Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Rheumatology Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Rheumatology Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Rheumatology Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Rheumatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Rheumatology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Rheumatology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Rheumatology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Rheumatology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Rheumatology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Rheumatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Rheumatology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Rheumatology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Rheumatology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Rheumatology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Rheumatology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rheumatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Rheumatology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Rheumatology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Rheumatology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Rheumatology Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Rheumatology Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Rheumatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Rheumatology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Rheumatology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Rheumatology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Rheumatology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Rheumatology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rheumatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Rheumatology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Rheumatology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Rheumatology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Rheumatology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Rheumatology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. AbbVie Company Details
Table 66. AbbVie Business Overview
Table 67. AbbVie Rheumatology Therapeutics Product
Table 68. AbbVie Revenue in Rheumatology Therapeutics Business (2016-2021) & (US$ Million)
Table 69. AbbVie Recent Development
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Rheumatology Therapeutics Product
Table 73. Pfizer Revenue in Rheumatology Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Pfizer Recent Development
Table 75. Bristol-Myers Squibb Company Company Details
Table 76. Bristol-Myers Squibb Company Business Overview
Table 77. Bristol-Myers Squibb Company Rheumatology Therapeutics Product
Table 78. Bristol-Myers Squibb Company Revenue in Rheumatology Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Bristol-Myers Squibb Company Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Rheumatology Therapeutics Product
Table 83. Merck Revenue in Rheumatology Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Amgen Company Details
Table 86. Amgen Business Overview
Table 87. Amgen Rheumatology Therapeutics Product
Table 88. Amgen Revenue in Rheumatology Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Amgen Recent Development
Table 90. Janssen Biotech Company Details
Table 91. Janssen Biotech Business Overview
Table 92. Janssen Biotech Rheumatology Therapeutics Product
Table 93. Janssen Biotech Revenue in Rheumatology Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Janssen Biotech Recent Development
Table 95. Novartis AG Company Details
Table 96. Novartis AG Business Overview
Table 97. Novartis AG Rheumatology Therapeutics Product
Table 98. Novartis AG Revenue in Rheumatology Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Novartis AG Recent Development
Table 100. Genentech Company Details
Table 101. Genentech Business Overview
Table 102. Genentech Revenue in Rheumatology Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Genentech Recent Development
Table 104. Takeda Pharmaceutical Company Details
Table 105. Takeda Pharmaceutical Business Overview
Table 106. Takeda Pharmaceutical Rheumatology Therapeutics Product
Table 107. Takeda Pharmaceutical Revenue in Rheumatology Therapeutics Business (2016-2021) & (US$ Million)
Table 108. Takeda Pharmaceutical Recent Development
Table 109. Sanofi Company Details
Table 110. Sanofi Business Overview
Table 111. Sanofi Rheumatology Therapeutics Product
Table 112. Sanofi Revenue in Rheumatology Therapeutics Business (2016-2021) & (US$ Million)
Table 113. Sanofi Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatology Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Rheumatoid Arthritis Features
Figure 3. Osteoarthritis Features
Figure 4. Lupus Features
Figure 5. Gout Features
Figure 6. Ankylosing Spondylitis Features
Figure 7. Other Features
Figure 8. Global Rheumatology Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Rheumatology Therapeutics Report Years Considered
Figure 13. Global Rheumatology Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Rheumatology Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Rheumatology Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Rheumatology Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Rheumatology Therapeutics Market Share by Players in 2020
Figure 18. Global Top Rheumatology Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatology Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Rheumatology Therapeutics Revenue in 2020
Figure 20. Global Rheumatology Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Rheumatology Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Rheumatology Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Rheumatology Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Rheumatology Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Rheumatology Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Rheumatology Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Rheumatology Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Rheumatology Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Rheumatology Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Rheumatology Therapeutics Market Share by Region (2016-2027)
Figure 42. China Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Rheumatology Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Rheumatology Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Rheumatology Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Rheumatology Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Rheumatology Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Rheumatology Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Rheumatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AbbVie Revenue Growth Rate in Rheumatology Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Rheumatology Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Therapeutics Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Rheumatology Therapeutics Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Rheumatology Therapeutics Business (2016-2021)
Figure 66. Janssen Biotech Revenue Growth Rate in Rheumatology Therapeutics Business (2016-2021)
Figure 67. Novartis AG Revenue Growth Rate in Rheumatology Therapeutics Business (2016-2021)
Figure 68. Genentech Revenue Growth Rate in Rheumatology Therapeutics Business (2016-2021)
Figure 69. Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Therapeutics Business (2016-2021)
Figure 70. Sanofi Revenue Growth Rate in Rheumatology Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---